Caris Life Sciences adds NYSE Texas dual listing
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Caris Life Sciences Inc (CAI)
Caris Life Sciences Inc stock price live, this page displays NASDAQ CAI stock exchange data. View the CAI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Caris Life Sciences Inc real time stock price chart below.
What Is the Caris Life Sciences Inc Stock Price Today?
The Caris Life Sciences Inc stock price today is 17.81.
What Is the Stock Symbol for Caris Life Sciences Inc?
The stock symbol for Caris Life Sciences Inc is "CAI."
What Stock Exchange Does Caris Life Sciences Inc Trade On?
Caris Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Caris Life Sciences Inc a Good Stock to Buy?
Determining whether Caris Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CAI quote. (ISIN: US1421521071)
What Is the Caris Life Sciences Inc Stock Price Today?
The Caris Life Sciences Inc stock price today is 17.81.
What Is the Stock Symbol for Caris Life Sciences Inc?
The stock symbol for Caris Life Sciences Inc is "CAI."
What Stock Exchange Does Caris Life Sciences Inc Trade On?
Caris Life Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Caris Life Sciences Inc a Good Stock to Buy?
Determining whether Caris Life Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CAI quote. (ISIN: US1421521071)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.50
18.59
52 wk Range
14.19
42.50
CAI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.5018.59
52 wk Range
14.1942.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CAI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
27.83
Upside
+56.28%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
6 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
10 Buy
3 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 27.83
(+56.28% Upside)
Caris Life Sciences Inc Earnings Call Summary for Q1/2026
- Q1 2026 revenue surged 79% YoY to $216M, driven by 85% growth in molecular profiling services; gross margin improved to 65% from 47%.
- EPS of $0 beat forecast of -$0.12 loss by 100%; posted fourth consecutive quarter of positive adjusted EBITDA at $26M with $23.5M free cash flow.
- Stock plunged 15.58% after-hours to $16.15, down 46% YTD and trading near 52-week low despite strong earnings performance.
- Launched Caris ChromoSeq and MI Clarity products; successfully refinanced debt extending maturity to 2031 to support growth initiatives.
- Guidance projects Q3 2026 revenue of $240.14M with EPS of $0.01; Q4 EPS forecast at $0.04 as company expands precision oncology market presence.
Last Updated: 2026-05-14, 06:18 a/m
Read Full TranscriptEarnings
Latest Release
May 07, 2026
EPS / Forecast
-- / -0.12
Revenue / Forecast
216.2M / --
Compare CAI to Peers and Sector
Metrics to compare | CAI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCAIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.2x | −46.1x | −0.4x | |
PEG Ratio | −0.15 | −1.04 | 0.00 | |
Price/Book | 8.5x | 2.0x | 2.6x | |
Price / LTM Sales | 5.5x | 11.5x | 3.0x | |
Upside (Analyst Target) | 52.8% | −4.5% | 51.8% | |
Fair Value Upside | Unlock | −35.8% | 7.2% | Unlock |
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company’s molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Caris Life Sciences (CAI) Stock Price Today?
The Caris Life Sciences stock price today is 17.81 USD.
What Stock Exchange Does Caris Life Sciences Trade On?
Caris Life Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Caris Life Sciences?
The stock symbol for Caris Life Sciences is "CAI."
What Is the Caris Life Sciences Market Cap?
As of today, Caris Life Sciences market cap is 5.18B USD.
What Is Caris Life Sciences's Earnings Per Share (TTM)?
The Caris Life Sciences EPS (TTM) is -1.80.
When Is the Next Caris Life Sciences Earnings Date?
Caris Life Sciences will release its next earnings report on Aug 18, 2026.
From a Technical Analysis Perspective, Is CAI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Caris Life Sciences Stock Split?
Caris Life Sciences has split 0 times.
How Many Employees Does Caris Life Sciences Have?
Caris Life Sciences has 1846 employees.
What is the current trading status of Caris Life Sciences (CAI)?
As of Jun 30, 2026, Caris Life Sciences (CAI) is trading at a price of 17.81 USD, with a previous close of 18.32 USD. The stock has fluctuated within a day range of 17.50 USD to 18.59 USD, while its 52-week range spans from 14.19 USD to 42.50 USD.
What Is Caris Life Sciences (CAI) Price Target According to Analysts?
The average 12-month price target for Caris Life Sciences is 27.83 USD, with a high estimate of 36 USD and a low estimate of 21 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +56.28% Upside potential.
What Is the CAI Premarket Price?
CAI's last pre-market stock price is 18.33 USD. The pre-market share volume is 1,250.00, and the stock has decreased by 0.01, or 0.05%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.